Holen Sie sich die Stockscreener-App
1.37
6.20%
0.08
Handel nachbörslich:
1.39
0.02
+1.46%
Schlusskurs vom Vortag:
$1.29
Offen:
$1.31
24-Stunden-Volumen:
177.75K
Relative Volume:
0.84
Marktkapitalisierung:
$65.40M
Einnahmen:
$2.72M
Nettoeinkommen (Verlust:
$-85.08M
KGV:
-0.7098
EPS:
-1.93
Netto-Cashflow:
$-70.93M
1W Leistung:
+3.01%
1M Leistung:
+19.13%
6M Leistung:
-60.06%
1J Leistung:
-84.45%
1-Tages-Spanne:
$1.31
$1.40
1-Wochen-Bereich:
$1.21
$1.40
52-Wochen-Spanne:
$0.94
$11.76
Shattuck Labs Inc Stock (STTK) Company Profile
Firmenname
Shattuck Labs Inc
Sektor
Branche
Telefon
512-900-4690
Adresse
500 W. 5TH STREET, AUSTIN
Vergleichen Sie STTK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
STTK
Shattuck Labs Inc
|
1.37 | 65.40M | 2.72M | -85.08M | -70.93M | -1.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Shattuck Labs Inc Stock (STTK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-10-02 | Herabstufung | Needham | Buy → Hold |
| 2024-10-01 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-06-17 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-08-31 | Eingeleitet | BTIG Research | Buy |
| 2022-06-01 | Eingeleitet | Citigroup | Buy |
| 2022-05-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-04-14 | Eingeleitet | Berenberg | Buy |
| 2021-01-11 | Eingeleitet | Evercore ISI | Outperform |
| 2020-11-03 | Eingeleitet | Citigroup | Buy |
| 2020-11-03 | Eingeleitet | Cowen | Outperform |
| 2020-11-03 | Eingeleitet | Needham | Buy |
Alle ansehen
Shattuck Labs Inc Aktie (STTK) Neueste Nachrichten
Shattuck Labs reports positive preclinical SL-325 data By Investing.com - Investing.com Nigeria
Shattuck Labs reports positive preclinical SL-325 data - Investing.com
Shattuck Labs Announces Positive Data from the Preclinical GLP Toxicology Study of SL-325 at the 20th Congress of European Crohn's and Colitis Organization (ECCO) in Inflammatory Bowel Diseases 2025 - The Manila Times
Shattuck Labs Announces Positive Data from the Preclinical GLP Toxicology Study of SL-325 at ... - The Bakersfield Californian
Breakthrough in IBD Treatment? Shattuck's Novel DR3 Blocker Achieves Perfect Safety Score - StockTitan
Shattuck Labs (STTK) Expected to Announce Earnings on Wednesday - Defense World
Shattuck Labs Announces Oral Presentation at Upcoming 20th Congress of European Crohn's and Colitis Organization (ECCO) in Inflammatory Bowel Diseases 2025 - The Manila Times
GoHealth to Announce Fourth Quarter 2024 Results on February 27, 2025 - The Manila Times
Revolutionary IBD Drug Development: Shattuck Labs Unveils Critical DR3 Antibody Results at ECCO 2025 - StockTitan
Shattuck Labs Reports Second Quarter 2024 Financial Results and Recent Business Highlights - br.ADVFN.com
Anti-DR3 antibody demonstrates efficacy in the treatment of IBD - BioWorld Online
Shattuck Labs Announces Poster Presentation at Upcoming 2025 Crohn's and Colitis Congress - The Manila Times
Skye Bioscience Announces Participation in February Conferences - The Manila Times
Shattuck Labs, Inc. to Present Novel Research on SL-325 at 2025 Crohn’s and Colitis Congress - Nasdaq
Pivotal IBD Drug Development: Shattuck Labs Reveals SL-325 Data at Major Crohn's Congress - StockTitan
JPMorgan Chase & Co. Grows Position in Shattuck Labs, Inc. (NASDAQ:STTK) - Defense World
Planet Image International Leads 3 US Penny Stocks To Consider - Simply Wall St
Cresco Labs (OTCMKTS:CRLBF) Trading 2.1% Higher – What’s Next? - Defense World
ImmunoMet Therapeutics Presents Updated Clinical Data from Phase 1b Study of Lixumistat in Pancreatic Cancer at ASCO-GI Meeting - BioSpace
Can ALX Break The CD47 Curse? - News & Insights
AXA (EPA:CS) Stock Price Crosses Above 200 Day Moving Average – Here’s Why - Defense World
Barclays PLC Has $189,000 Stock Holdings in Shattuck Labs, Inc. (NASDAQ:STTK) - Defense World
Layoff Tracker: Notch Therapeutics to ‘Significantly Reduce’ Workforce - BioSpace
Stabilus (OTCMKTS:SBLUY) Stock Price Up 10.9% – Still a Buy? - Defense World
Shattuck Labs, Inc. (NASDAQ:STTK) Shares Sold by Jane Street Group LLC - Defense World
Luna Innovations Incorporated (NASDAQ:LUNA) Shares Sold by Jane Street Group LLC - Defense World
Jane Street Group LLC Boosts Stock Holdings in System1, Inc. (NYSE:SST) - Defense World
Barclays PLC Buys 40,717 Shares of Shattuck Labs, Inc. (NASDAQ:STTK) - Defense World
Geode Capital Management LLC Raises Position in Shattuck Labs, Inc. (NASDAQ:STTK) - Defense World
Shattuck Labs CEO to Present at J.P. Morgan Healthcare Conference 2025 - StockTitan
Shattuck Labs highlights upcoming key milestones in 2025 - Yahoo Finance
Shattuck Labs gears up for DR3 antagonist trials in 2025 By Investing.com - Investing.com Australia
Shattuck Labs gears up for DR3 antagonist trials in 2025 - Investing.com
Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2025 - The Manila Times
Shattuck Labs Unveils 2025 Pipeline Roadmap: Key SL-325 Clinical Milestones, $90M Cash Position - StockTitan
State Street Corp Acquires 55,579 Shares of Shattuck Labs, Inc. (NASDAQ:STTK) - Defense World
Barfresh Food Group And 2 Other US Penny Stocks To Consider - Simply Wall St
STTK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Shattuck Labs, Inc. and Encourages Investors to Contact the Firm - The Eastern Progress Online
MetLife Investment Management LLC Raises Holdings in Shattuck Labs, Inc. (NASDAQ:STTK) - Defense World
STTK LAWSUIT ALERT: Levi & Korsinsky Notifies Shattuck Labs, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - Marketscreener.com
Shattuck Labs, Inc. (NASDAQ:STTK) Director Buys $166,713.75 in Stock - MarketBeat
Redmile Group, LLC Reduces Stake in Shattuck Labs Inc - GuruFocus.com
Shattuck Labs sees $166,713 in stock sales by Redmile Group - Investing.com
New VC fund from hedge fund luminary seeks to raise $100M, filing shows - The Business Journals
GSA Capital Partners LLP Invests $121,000 in Shattuck Labs, Inc. (NASDAQ:STTK) - Defense World
Shattuck Labs to Present at Piper Sandler and Evercore Healthcare Conferences | STTK Stock News - StockTitan
Shattuck Labs Falls To US$1.01, But Insiders Sold At Lower Price - Simply Wall St
Shattuck Labs stock plunges to 52-week low at $1.06 By Investing.com - Investing.com Canada
Shattuck Labs stock plunges to 52-week low at $1.06 - Investing.com India
Citigroup Downgrades Shattuck Labs (STTK) - MSN
Shattuck Labs’ (STTK) Neutral Rating Reaffirmed at HC Wainwright - Defense World
Finanzdaten der Shattuck Labs Inc-Aktie (STTK)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.27%
3.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):